At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
buckwheat, rice crackers, glucose, sugar substituteother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-Blind, Randomized, Controlled Study to Determine Buckwheat's Glucose Lowering Effects in Healthy Volunteers and Volunteers With Type 2 Diabetes
In Brief
An observational study evaluating buckwheat, rice crackers, glucose, sugar substitute for Type 2 Diabetes. Completed, enrolled 24 participants across 1 site.
Detailed Summary
Bioactive components in buckwheat enhance insulin sensitivity in Type 2 diabetes by improving glucose uptake and utilization through a unique mechanism that operates independent of insulin.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesCanada
CollaboratorsUniversity of Manitoba
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2008
First PostedFeb 2009
Primary CompletionMar 2012
TodayJul 2026
First PostedFeb 11, 2009
Enrollment StartSep 1, 2008
Primary CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 17.4 years ago
Interventions
buckwheat, rice crackers, glucose, sugar substituteother
crackers contain equal amounts of available carbohydrates; 50 mls of oral solution for both glucose and Splenda